#United States #MPM Medical #Collagen #FDA 510(k) #Mesquite

MPM Medical Expands U.S. Manufacturing Capabilities

MPM Medical, a key player in the advanced wound care industry, has announced significant strides in its U.S. manufacturing capabilities by acquiring a comprehensive collagen manufacturing system. This expansion is pivotal in solidifying the company’s position as a leader in producing high-quality, American-made collagen products, particularly for surgical and wound care applications.

The news comes hot on the heels of the recent launch of MPM Medical’s Collagen At-Home Wound Care Kits and their proprietary Wound Care Portal, which are designed to support healthcare professionals and patients alike. The new collagen manufacturing platform has received FDA 510(k) clearance, reflecting the company's commitment to safety and efficacy in its product offerings.

New Manufacturing Facility and Advanced Technology

Starting January 1, 2026, the collagen production operations will take place at MPM Medical’s state-of-the-art facility in Mesquite, Texas, which spans an impressive 100,000 square feet. The expansion features advanced processing technologies, including high-capacity lyophilizers and USP-grade compounding. This setup is expected to significantly enhance the overall output of both the company’s branded products and increased private-label demand from partners.

Extensive Collagen Product Lineup

As part of this expansion, MPM Medical’s collagen portfolio has broadened to include:

• - MetaMatrix™ Antibacterial Surgical Collagen Powder
• - ACM™ Surgical Collagen Pads
• - TripleHelix™ Advanced Wound Care Collagen Powder, Pads, and Ropes
• - At-Home Collagen Wound Care Kits

All products are manufactured in the U.S. using non-hydrolyzed Type I bovine collagen and are free from added chemicals, ensuring minimal endotoxin and low pH for enhanced biocompatibility in medical environments.

Commitment to U.S.-Based Manufacturing

MPM Medical’s upgraded facility in Mesquite is equipped with Class 8 cleanrooms and full microbiology and analytical testing laboratories, adhering to strict FDA regulations and current Good Manufacturing Practices (cGMP). The company’s commitment to quality control not only fulfills regulatory standards but also amplifies the operational capacity needed to respond to the growing demand for reliable, U.S.-made collagen in the healthcare market.

Director of Marketing, Marissa Ransdell, emphasized the current market dynamics stating, "With supply chain unpredictability and escalating manufacturing costs globally, there is a heightened demand for trustworthy, domestically produced collagen products. Our expansion equips us to meet this critical need, ensuring quicker response times and unparalleled flexibility for our private-label partners."

Innovating for the Future

By shifting surgical and wound care collagen manufacturing in-house, MPM Medical aims to foster innovation, scale production responsibly, and provide partners with reliable, FDA-cleared solutions. CEO Sudheer Kancherla remarked, "This milestone is not just significant for MPM Medical, but it also benefits every clinician and organization needing dependable, American-made collagen products."

Opportunities for Collaboration

MPM Medical is eager to collaborate with various healthcare entities, including:

• - Surgical centers and hospitals
• - Wound care distributors
• - OEM device manufacturers
• - International healthcare organizations

For those interested in exploring private-label manufacturing options or transitioning existing collagen products to U.S.-based production, the company invites inquiries through their website.

In summary, MPM Medical’s manufacturing expansion underscores its commitment to quality and accessibility in advanced wound care solutions, securing its role as a trusted provider in the U.S. market. Their new products reflect not only innovation but a deep responsibility to enhance patient outcomes through cutting-edge medical advancements.

For more information, visit mpmmed.com or reach out to Marissa Ransdell, Marketing Director, via email.